However, still, the evaluation of EGFR as a potential biomarker in phyllodes tumors has not been well established, moreover, Tse12 suggested that the activation of EGFR mediated by EGF-family ligands is not the only mechanism by which proliferation occurs in phyllodes tumors. The gene discussed is EGFR; the disease is phyllodes tumor.